JP Morgan Assumes CRH at Overweight, Raises Price Target to $130 You are unauthorized to view this page. Username Password Remember Me Forgot Password
HC Wainwright & Co. Assumes Monopar Therapeutics at Buy, Announces Price Target of $70 You are unauthorized to view this page.
B. Riley Securities Initiates Coverage On Actuate Therapeutics with Buy Rating, Announces Price Target of $20 You are unauthorized to view this page.
tm
tm